Home

We partner with early stage ventures to build companies that transform lives and industries.

About Us

Since 1962, Elron has been at the forefront of Israeli innovation, as founders and early investors in companies such as Elbit Systems, Elscint, Zoran, Partner, Netvision and Given Imaging.

Today we remain committed to our vision of identifying transformative technologies, nurturing gifted entrepreneurs, and building companies into technology leaders.

Our team is dedicated to attracting and supporting imaginative and focused entrepreneurs and startups with never-been-done-before ideas. Group companies benefit from our combined technological, strategic, entrepreneurial & business expertise, broad networks, and wide attention span.

A word from our founder

Where We Invest

We invest in treatment-changing (rather than treatment-enhancing) medical device companies. We seek companies with billion-$ market potential. We usually invest in the idea/R&D stage.
We invest in exceptional ideas and technologies with the potential to transform or create new markets, and help make the world a more secure place to live in. We seek investment opportunities from seed to growth stages.

RDC

Strategic JV

RDC was founded in 1993 by Elron and Rafael, a global leader of defense technologies and one of Israel's largest defense companies. RDC combines Rafael's scale and technological edge, with Elron's vast expertise in helping startups develop into leading tech companies.

Through RDC, which has exclusive rights to commercialize Rafael's defense technologies in civilian markets, we initiate and develop new companies, and provide essential support from start to exit.

Since its inception, RDC has successfully invested in numerous hi-tech companies. A prime example of RDC's active end-to-end involvement in the growth of its companies is Given Imaging. Given Imaging redefined gastrointestinal disease diagnosis by developing the PillCam ingestible video capsule, based on a unique technology initially invented for military purposes. After becoming a world leader in its field, Given Imaging was acquired for $1 billion.

How We Invest

We aim high.

We invest primarily in early stage ventures with significant exit potential, in which we seek significant shareholder stakes, enabling us to provide hands-on support and contribute from our experience.

We become involved.

We play a defining role in the development of our group companies, by means of active involvement in all aspects of their business and day-to-day operations, to help them reach their long-term objectives.

We are committed.

As an operational holding company that invests its own capital in new and existing group companies, we have the flexibility to support the growth of our group companies over the long term, weather setbacks, and maximize exit events.

Key Stats

$1.5b

value of exit transactions since 2010

$246m

investments since 2010

$140m

dividends distributed since 2010

12

M&As since 2010

$188m

total amount invested in current group companies

News

More news

CPT codes for home OCT established

January 8, 2020

The AMA’s CPT® Editorial Panel has accepted three new category III codes for reporting patient-initiated remote retinal OCT scans, facilitated by Notal Vision’s home-based OCT pipeline technology

Read More
Elron & RDC Newsletter – December 2019

Elron & RDC Newsletter – December 2019

December 19, 2019

A look back at 2019: As we approach the end of 2019, it is a great opportunity to reflect on the busy year we’ve had and all that we’ve achieved.

Read More

Alcide Releases 2020 Predictions: Kubernetes on the Edge, Intelligent and Automated K8s Security

December 18, 2019

Latest Alcide survey shows skills gap for companies using Kubernetes and an intent to increase use of security tools

Read More
More news